Bunkerhill Raises $55M for Hospital-Built Clinical AI Agents
Agentic AI Moves from Drafting to Routing Patients
Bunkerhill Health has secured Series B funding led by Khosla Ventures, totaling $55 million, to scale its Carebricks platform. This enables healthcare systems to build and deploy their own clinical AI agents instead of purchasing vendor point-tools.
The Platform: From Passive Documentation to Active Action
The platform allows AI agents to monitor unstructured data, prioritize cases, and route patients, shifting agentic AI from note-drafting to active workflow participation. This is a significant shift mirroring the trend in enterprise software where platforms enable companies to deploy governed AI agents across various workflows.
Highlighted Successes from UTMB
Bunkerhill claims over 20 live agents at the University of Texas Medical Branch (UTMB), including:
- A coronary calcium agent using an FDA-cleared algorithm that routed a patient with imminent heart attack risk to cardiology, leading to life-saving triple bypass surgery.
- A nephrology triage agent reducing specialist wait times by over half.
- A lung-nodule agent addressing urgent findings 80% faster.
Caveats and Considerations
While these results are impressive, they should be viewed critically:
- The data comes from a single institution and is supplied by Bunkerhill without independent audit.
- Only some algorithms are FDA-cleared.
- AI agents making patient routing decisions carry significant medical liability, raising questions about accountability.
Investor Interest in Adoption Over Novelty
Vinod Khosla argued that Bunkerhill’s focus on adoption, rather than technological novelty, is a compelling investment opportunity for investors.